Submit Deal

ARCHON BIOSCIENCES

Summary

Archon Biosciences is a biotechnology company pioneering computationally designed Antibody Cages (AbCs) to unlock powerful therapeutic targets beyond the reach of existing modalities

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 15 M

Avg. Deal Size£ 15 M

Market Context

Senior Management

James Lazarovits
CEO and Co-founder

Sort

30 Oct 2024|United States|Biotechnology

Target: ARCHON BIOSCIENCES

Bidder: DUMAC

3 Service Providers

2 Target | 1 Bidder

2 Dealmakers

1 Target | 1 Bidder

£ 15 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy